General

Trends in Phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012–2022

By |2024-08-08T06:02:52+00:00August 8th, 2024|General|

CTA is pleased to support the recent publication by Hitchen N, Shahnam A, Manoharan S et al, reviewing trends in Phase 1 oncology clinical trials across Australia. This paper [...]

Trial data in the AI age; New Member-elected Board Appointment of Dr Dishan Herath

By |2024-07-31T01:53:19+00:00July 31st, 2024|General|

With both artificial intelligence and cybersecurity now squarely in the public eye, Dr. Dishan Herath brings a new perspective as the newest member of the Cancer Trials Australia Board. [...]

CTA’s Developmental Therapeutics Update Dinner Series draws to a close for the second year

By |2023-12-01T04:59:37+00:00December 1st, 2023|General|

In late November CTA was pleased to host our second Developmental Therapeutics Update Dinner meeting for 2023, presented with the generous support of the Series sponsors, namely Amgen, AstraZeneca, [...]

10,000th Australian patient accrued by ground-breaking cancer trials collaborative

By |2020-10-20T01:33:34+00:00October 20th, 2020|General|

In a major milestone for Australian cancer patients, the not-for-profit, member-based organisation, Cancer Trials Australia (CTA), has recently marked the recruitment of the 10,000th oncology patient to clinical trials [...]

CTA CEO discusses key considerations for Chinese biotechs considering conducting clinical trials in Australia

By |2019-11-15T03:33:55+00:00November 15th, 2019|General|

Cancer Trials Australia’s CEO, Dr. Kurt Lackovic, was a panelist at the 12th annual ‘China Trials – Clinical Development Leaders’ summit’ in Shanghai this week.  Other panelists included Jayden [...]

CTA announces partnership to drive Teletrials forward at Victorian study sites

By |2019-11-19T04:13:17+00:00November 11th, 2019|General|

Cancer Trials Australia (CTA) is pleased to announce a new project, to be delivered with the Victorian Comprehensive Cancer Centre (VCCC), providing Victorian sites with an exciting opportunity to [...]

CTA CEO presents at 3rd Annual Accelerating Clinical Trials in Asia conference

By |2019-11-11T04:18:16+00:00September 26th, 2019|General|

By 2021, the global market for clinical trials is anticipated to grow to $60Bn, a 75% increase over 2015. The largest contributor to this huge growth is the Asia-Pacific region.Cancer [...]

Coordinated Electronic Document Management for Victorian study sites

By |2019-08-20T13:42:14+00:00November 22nd, 2018|General|

CTA announces partnership in delivering coordinated Electronic Document Management for Victorian study sites Cancer Trials Australia (CTA) is pleased to announce a new project funded by the Victorian Comprehensive [...]

Go to Top